Trial intelligence / Profile preview

Rocuronium-Sugammadex vs Succinylcholine in Rapid Sequence Intubation

NCT00953550Phase 4Completed

Sponsor
Rigshospitalet
Start
Sep 2009
Primary completion
Jan 2011
Modality
Biodegradable Polymers, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Sugammadex, rocuronium in pulmonary aspiration, sponsored by Rigshospitalet. Started Sep 2009; status: completed.

02

Drugs

Sugammadexrocuronium
03

Conditions

pulmonary aspiration

Beyond the preview

Go deeper on NCT00953550.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00953550.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call